Literature DB >> 15860896

Safety of exemestane in the Intergroup Exemestane Study.

R Charles Coombes, Judith M Bliss, Emma Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15860896     DOI： 10.1200/JCO.2005.05.361

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Aromatase inhibitors: past, present and future in breast cancer therapy.

Authors:  Udayan Dutta; Kartikeya Pant
Journal:  Med Oncol       Date:  2007-11-01       Impact factor: 3.064

2.  A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?

Authors:  Daniel F Hayes; Vered Stearns; James Rae; David Flockhart
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

3.  Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES.

Authors:  M C U Cheang; J M Bliss; G Viale; V Speirs; C Palmieri; A Shaaban; P E Lønning; J Morden; N Porta; J Jassem; C J van De Velde; B B Rasmussen; D Verhoeven; J M S Bartlett; R C Coombes
Journal:  Breast Cancer Res Treat       Date:  2017-11-24       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.